Heart failure affects 26 million people worldwide. Half die within five years of diagnosis. There's been a lack of progress in finding more effective medications. Advances in understanding mean new options for patients and caregivers.

Two scientists from Basel are trying to shed light on why myopia is impacting more and more people.

Low- and middle-income countries will account for some three in four of the world’s cancer deaths within the next decade without better access to care. It’s a gap Amy Israel and her team at Novartis are trying to bridge.

Raising awareness of the ways in which prostate cancer can affect the sexual minority and gender minority communities.

The head of Public Affairs for the Novartis Malaria Initiative has a malaria story of her own to tell.

Efforts are underway to reinforce health education and healthcare delivery in rural Vietnam to combat a rise in chronic diseases such as diabetes, hypertension and respiratory ailments.

The best treatment for multifaceted diseases like NASH may be combinations of drugs.

Public health expert Richard Laing discusses how independent measurement of access programs can help ensure their success